Beijing banned imports of Illumina’s gene-sequencing machines in response to U.S. tariffs.

In its fourth quarter 2024 investor letter, Brown Advisors Global Leaders Strategy emphasized stocks such as Illumina, Inc. (NASDAQ:ILMN). Illumina, Inc. (NASDAQ:ILMN) offers sequencing- and array ...

For the first time, China has put American genome-sequencing equipment manufacturer Illumina on its “unreliable entity list”. The move was a direct counter to the US imposing sanctions on Beijing ...

Illumina reported Q3 2024 revenue of $1.08 billion -- in line with analysts' consensus estimate. Non-GAAP EPS was $1.14, exceeding the $0.879 consensus and indicating strong cost control. Despite ...